The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to…
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc.…
US equity markets opened sharply higher this morning and have been able to sustain and even add to those gains throughout the day. Business and consumer confidence indexes in Europe were higher,…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) Added to Strong Buy List at Zacks…
US equity markets opened solidly higher this morning, but began to lose momentum by mid-morning. From there it’s been a mostly downhill day with the DJIA creeping back to nearly flat with…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Amgen Inc. (NASDAQ: AMGN) Raised to Neutral with $57.00 price target objective…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. Alcoa, Inc. (NYSE: AA) Cut to Neutral from Buy at Goldman Sachs.…
Stocks opened a bit lower this morning, but almost immediately turned around without being able to break through the opening numbers. Revised third-quarter US GDP numbers were worse than expected, falling to…
These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at BMO. AutoNation Inc. (NYSE: AN) Raised to…
These are some of Monday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at Leerink Swann. Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN)…
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are extraordinarily high,…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Started as Outperform at BMO. Ariad…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US…
If you have been a reader of 24/7 Wall St. for long, you know that we appreciate companies that pay dividends just about as much the investors who buy companies because of…
Earnings season is in full throttle and many major companies are due to report in the week ahead. Some of the key reports we are featuring for detailed earnings previews are the…
